Cargando…
Programmed Cell Death-Ligand 2: A Neglected But Important Target in the Immune Response to Cancer?
Programmed cell death-ligand 2 (PD-L2) is one of the two ligands of the programmed cell death-1 (PD-1) receptor, an inhibitory protein mainly expressed on activated immune cells that is targeted in the clinic, with successful and remarkable results. The PD-1/PD-Ls axis was shown to be one of the mos...
Autores principales: | Solinas, Cinzia, Aiello, Marco, Rozali, Esdy, Lambertini, Matteo, Willard-Gallo, Karen, Migliori, Edoardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7332529/ https://www.ncbi.nlm.nih.gov/pubmed/32622310 http://dx.doi.org/10.1016/j.tranon.2020.100811 |
Ejemplares similares
-
Programmed Death Ligand 2 in Cancer-Induced Immune Suppression
por: Rozali, Esdy N., et al.
Publicado: (2012) -
LAG3: The Biological Processes That Motivate Targeting This Immune Checkpoint Molecule in Human Cancer
por: Solinas, Cinzia, et al.
Publicado: (2019) -
A critical evaluation of glucocorticoids in the management of severe COVID-19
por: Solinas, Cinzia, et al.
Publicado: (2020) -
The rationale behind targeting the ICOS-ICOS ligand costimulatory pathway in cancer immunotherapy
por: Solinas, Cinzia, et al.
Publicado: (2020) -
Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression
por: Pellegrino, Benedetta, et al.
Publicado: (2021)